Increased risk of leukemia relapse with high dose cyclosporine after allogeneic marrow transplantation for acute leukemia: 10 year follow-up of a randomized study.

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Blood

• Publication date

  2001-11-15

• Fields of study

  Medicine

• Identifiers
  DOI 10.1182/BLOOD.V98.10.3174PMID 11721685
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Clinical and virologic characteristics of chronic active Epstein-Barr virus infection.

  2001cited by this paper
• Epstein-Barr virus--associated diseases in humans.

  2000cited by this paper
• Blood stem-cell transplantation for chronic active Epstein-Barr virus with lymphoproliferation.

  2000cited by this paper
• Graft versus host disease prophylaxis with low-dose cyclosporine-A reduces the risk of relapse in children with acute leukemia given HLA-identical sibling bone marrow transplantation: results of a randomized trial.

  2000cited by this paper
• The association of latent Epstein–Barr virus infection with hydroa vacciniforme

  1999cited by this paper
• Hypersensitivity to Mosquito Bites Conceals Clonal Lymphoproliferation of Epstein‐Barr Viral DNA‐positive Natural Killer Cells

  1997cited by this paper
• Chronic active Epstein‐Barr virus infection in children in Japan

  1995cited by this paper
• Alloimmune neonatal neutropenia due to an antibody to the neutrophil Fc-gamma receptor III with maternal deficiency of CD16 antigen.

  1991cited by this paper
• Increased risk of leukemia relapse with high-dose cyclosporine A after allogeneic marrow transplantation for acute leukemia.

  1991cited by this paper
• CD3-negative lymphoproliferative disease of granular lymphocytes containing Epstein-Barr viral DNA.

  1989cited by this paper

• Optimizing Donor Choice and GVHD Prophylaxis in Allogeneic Hematopoietic Cell Transplantation.

  2021cites this paper
• Post-transplant cyclophosphamide use in matched HLA donors: a review of literature and future application

  2019cites this paper
• Influence of Age on Acute and Chronic GVHD in Children Undergoing HLA-Identical Sibling Bone Marrow Transplantation for Acute Leukemia: Implications for Prophylaxis.

  2018influential citation
• Disease Susceptibility to Graft-vs-Malignancy Effects

  2017cites this paper
• Allogeneic Hematopoietic Stem Cell Transplantation in patients with Acute Myeloid Leukemia : a personalized approach

  2017cites this paper
• In search of the optimal platform for Post-Allogeneic SCT immunotherapy in relapsed multiple myeloma: a systematic review

  2017cites this paper
• High-dose cyclophosphamide as single agent, short-course prophylaxis of graft-

  2017cites this paper
• Relapse assessment following allogeneic SCT in patients with MDS and AML

  2014cites this paper
• Single infusion of donor mononuclear early apoptotic cells as prophylaxis for graft-versus-host disease in myeloablative HLA-matched allogeneic bone marrow transplantation: a phase I/IIa clinical trial.

  2014cites this paper
• of graft-versus-host disease High-dose cyclophosphamide as single-agent, short-course prophylaxis

  2013cites this paper
• Donor T cell outcome and immune reconstitution following post-transplant cyclophosphamide and regulatory MHC cell therapy in recipients of mhc matched allogeneic hematopoietic stem cell transplants

  2012cites this paper
• Cyclosporine levels and rate of graft rejection following non-myeloablative conditioning for allogeneic hematopoietic SCT

  2011cites this paper
• High-dose, post-transplantation cyclophosphamide to promote graft-host tolerance after allogeneic hematopoietic stem cell transplantation

  2010cites this paper
• Novel Approaches to Prevent Leukemia Relapse Following Allogeneic Hematopoietic Cell Transplantation

  2010cites this paper
• Antimykose in der Hämatoonkologie

  2010cites this paper
• High-dose cyclophosphamide as single-agent, short-course prophylaxis of graft-versus-host disease.

  2010cites this paper
• High-dose cyclophosphamide for graft-versus-host disease prevention

  2010cites this paper
• The Impact of Desferrioxamine Postallogeneic Hematopoietic Cell Transplantation in Relapse Incidence and Disease-Free Survival: A Retrospective Analysis

  2010cites this paper
• Graft-versus-disease effect following allogeneic transplantation for acute leukaemia.

  2008cites this paper
• Randomised trials of Graft versus Host Disease prophylaxis in haemopoietic stem cell transplantation.

  2008cites this paper
• Advances in pediatric hematopoietic stem cell transplantation

  2008cites this paper
• Oral beclomethasone dipropionate in gastrointestinal graft-versus-host disease

  2007cites this paper
• Allogeneic hemopoietic stem cell transplants for patients with relapsed acute leukemia: long-term outcome

  2007cites this paper
• Management of acute graft‐versus‐host disease

  2007influential citation
• Optimizing the use of cyclosporin in allogeneic stem cell transplantation

  2006cites this paper
• Prognostic factors for outcomes of patients with refractory or relapsed acute myelogenous leukemia or myelodysplastic syndromes undergoing allogeneic progenitor cell transplantation.

  2005cites this paper
• Targeted immunotherapy in acute myeloblastic leukemia: from animals to humans

  2005cites this paper
• Prompt initiation of immunotherapy in children with an increasing number of autologous cells after allogeneic HCT can induce complete donor-type chimerism: a report of 14 children

  2004cites this paper
• Diagnosis and prognosis of breast and ovarian cancer A population-based study of 234 women

  2004cites this paper
• Outcome of single fraction total body irradiation-conditioned stem cell transplantation in younger children with malignant disease Comparison with a busulphan-cyclophosphamide regimen

  2004cites this paper
• Effect of graft-versus-host disease on the outcome of bone marrow transplantation from an HLA-identical sibling donor using GVHD prophylaxis with cyclosporin A and methotrexate

  2004cites this paper
• Management of acute graft versus host disease (GvHD).

  2004cites this paper
• Should we T-cell deplete sibling grafts for acute myeloid leukaemia in first remission?

  2004cites this paper
• Nonmyeloablative preparative regimens for allogeneic hematopoietic transplantation. Biology and current indications.

  2003cites this paper
• Should we T cell deplete sibling grafts for acute myeloid leukaemia in first remission?

  2003cites this paper
• Critical factors in optimizing graft-versus-leukemia effect for relapsed leukemias.

  2002cites this paper
• Germ cell transplantation.

  2002cites this paper